 | Articles: Drug Trials |
Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis
Corporate News Releases, 03/09/06
Santarus Announces Positive Results with ZEGERID in Nocturnal Acid Breakthrough Clinical Study
Corporate News Releases, 03/09/06
77% achieve acr20 with genmab’s humax-cd20 in rheumatoid arthritis study
Genmab, 03/09/06
 | | Sponsor |
Endovasc Submits Protocol for Phase III Clinical Trial of Liprostin
Endovasc Ltd., 03/08/06
Novo Nordisk Reinitiates Phase 3 Inhalable Insulin Plan
Corporate News Releases, 03/08/06
REMICADE (infliximab) Phase 3 Data Show Rapid And Significant Improvement And Long-Term Response In The Treatment Of Moderate To Severe Psoriasis
Johnson & Johnson, 03/06/06
TYSABRI Two-Year Phase III Multiple Sclerosis Clinical Trial Results and Safety Evaluation Published in New England Journal of Medicine; TYSABRI Currently Under Review with U.S. and European Regulatory Authorities
Elan, 03/02/06
TorreyPines Alzheimers drug enters second phase I trial
Corporate News Releases, 03/01/06
Cipralex - new data supports the superiority of Cipralex compared to Paxil/Seroxat
Lundbeck, 02/28/06
Positive Findings from Clinical Studies of QUADRAMET(R) in Prostate Cancer Patients with Metastatic Bone Disease Presented at ASCO Prostate Cancer Symposium
Cytogen, 02/28/06
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
